Replies to post #362297 on Elite Pharmaceuticals Inc (ELTP)

[DSherman]

Well, your creds put you at the top of the hill with Elite and always have, Congratz!!!

[namtae]

Remember when the evidence is clear and decisive, born of past practice by the FDA, Elite will receive approval for SequestOx on or before July 14th (three days hence) AND WITH THE ALL-IMPORTANT ADF LABEL?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=123800155

[dr_lowenstein]

nonsense, SA does not require such "evidence"

[jgsnys]

Nasrat breaks new ground with his use of the term "silly" on a CC.
'no2koolaid'- For "extra-credit" (a term you are no doubt very familiar with, you might see if you can find any other conference-calls wherein the CEO used the term "silly". It is quite understandable for my man NAZ to tend away from all consideration of anything "serious". Enlighten us if you would, as certainly your intellectual domain encompasses all things deemed "silly".
-Thanks.

. . . Shouldn't you be accumulating at these prices?
"Buy the silly!" . . . "How far down the rabbit-hole do you want to go?"

[The ELTP King]

When are we going to get an UPDATED Seeking Alpha article on Elite?

We need one soon!

Preferably right after the February 2022 conference call and earnings report.

Thanks!

In the 5 years I have been writing on SA I have published only one article on Elite. So, I am hardly a shill for them. However, two things about that Elite article. First, it bears reading in light of what we heard on the CC today. Secondly, consider that my author’s rating on SA is as much as 10X higher than many of those selling their business investment influence on SA. Even Avisol Partners, a group that I respect and that writes every day, has a rating 50% lower than mine. What that tells you is my 1,552 followers (as of today) believe in what I say. But I do not write for followers, I do not write for the small stipend I get from SA, I do not write to influence investors and have never recommended a buy or sell rating on any company I have written about (some have criticized me for failing to provide such investment advice), and I do not write to impress anyone. I write when I have something to say that is strategy related, and I have the time. With that, here is the Elite article I wrote December 31, 2019. https://seekingalpha.com/article/4314697-not-all-strategic-transformations-are-elite-this-one-is